UBE2I Protein
Kurzübersicht für UBE2I Protein (ABIN7198588)
Target
Alle UBE2I Proteine anzeigenProtein-Typ
Spezies
Quelle
Reinheit
- 
    - 
                                            Verwendungszweck
- Recombinant Human UBE2I/UBC9 Protein
- 
                                            Sequenz
- Met 1-Ser 158
- 
                                            Produktmerkmale
- A DNA sequence encoding the human UBE2I (P63279) (Met 1-Ser 158) was expressed and purified, with additional two amino acids (Gly & Pro) at the N-terminus.
 
- 
                                            
- 
    Möchten Sie weitere Optionen für dieses Protein ?!Entdecken Sie unsere vordefinierten maßgeschneiderten Proteine und Proteinservices!Ihr Projekt erfordert weitere Anpassungen? Kontaktieren Sie uns und entdecken Sie unsere maßgeschneiderten Proteinlösungen 
- 
    
- 
    - 
                                            Beschränkungen
- Nur für Forschungszwecke einsetzbar
 
- 
                                            
- 
    - 
                                            Format
- Lyophilized
- 
                                            Rekonstitution
- Please refer to the printed manual for detailed information.
- 
                                            Buffer
- Lyophilized from sterile PBS, 10 % glycerol, 2 mM DTT, pH 7.4
- 
                                            Lagerung
- 4 °C,-20 °C,-80 °C
- 
                                            Informationen zur Lagerung
- Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80°C. Reconstituted protein solution can be stored at 4-8°C for 2-7 days. Aliquots of reconstituted samples are stable at < -20°C for 3 months.
 
- 
                                            
- 
    - UBE2I (Ubiquitin-Conjugating Enzyme E2I (UBE2I))
- 
                                            Andere Bezeichnung
- UBE2I/UBC9
- 
                                            Hintergrund
- 
                        Background: UBE2I is a member of the ubiquitin-conjugating E2 family whose members perform the second step in the ubiquitination reaction. Initially identified as the main process for protein degradation; ubiquitination is believed nowadays to be crucial for a wider range of cellular processes. The outcome of the ubiquitin-conjugation reaction; and thereby the fate of the substrate; is heavily dependent on the number of ubiquitin molecules attached and how these ubiquitin molecules are inter-connected. To deal with this complexity and to allow adequate ubiquitination in time and space; a highly sophisticated conjugation machinery has been developed. In a sequential manner; ubiquitin becomes activated by an ubiquitin-activating enzyme (E1); which then transfers the ubiquitin to a group of ubiquitin-conjugating enzymes (E2s). Next; ubiquitin-loaded E2s are interacting with ubiquitin protein ligases (E3s) and ubiquitin is conjugated to substrates on recruitment by the E3. These three key enzymes are operating in a hierarchical system; wherein two E1s and 35 E2s have been found and hundreds of E3s have been identified in humans. Synonym: SUMO-Conjugating Enzyme UBC9; SUMO-Protein Ligase; Ubiquitin Carrier Protein 9; Ubiquitin Carrier Protein I; Ubiquitin-Conjugating Enzyme E2 I; Ubiquitin-Protein Ligase I; p18; UBE2I; UBC9; UBCE9 
- 
                                            UniProt
- P63279
- 
                                            Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Ubiquitin Proteasome Pathway
 Target
- 
                    
 
                                     
                                     
                                    